title: Tumor response to sunitinib malate observed in clear-cell sarcoma.
authors.forename: S
authors.initials: S
authors.lastname: Stacchiotti
authors.forename: F
authors.initials: F
authors.lastname: Grosso
authors.forename: T
authors.initials: T
authors.lastname: Negri
authors.forename: E
authors.initials: E
authors.lastname: Palassini
authors.forename: C
authors.initials: C
authors.lastname: Morosi
authors.forename: S
authors.initials: S
authors.lastname: Pilotti
authors.forename: A
authors.initials: A
authors.lastname: Gronchi
authors.forename: P G
authors.initials: PG
authors.lastname: Casali
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008875:Middle Aged; D011758:Pyrroles / Q000627:therapeutic use*; D018227:Sarcoma, Clear Cell / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D012983:Soft Tissue Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D000077210:Sunitinib; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib